Carisoprodol 350 MG Oral Tablet — RxCUI 197446
RxNorm drug concept · Semantic clinical drug
RxCUI 197446
Semantic clinical drug · SCD
● Current RxNorm concept 51 FDA products
147 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI197446
Official nameCarisoprodol 350 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped51
Package NDCs mapped147
Reported Medicaid activity (SDUD)38,417 prescriptions · 35 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Carisoprodol: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Carisoprodol — you may know it by the brand name Soma — is a short-term muscle relaxant for adults dealing with acute muscle pain and discomfort, like a back injury or muscle strai...
- Yes, drowsiness is the most common side effect — it happened in up to 17% of people in clinical trials. You should not drive or operate heavy machinery until you know how carisopro...
- Will it make me really drowsy? Can I drive?
- There is a real risk. Carisoprodol can be habit-forming, and cases of abuse and dependence have been reported — especially with prolonged use or in people with a history of substan...
🕸️ Concept Web — How Carisoprodol 350 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Carisoprodol 350 MG Oral Tablet
RxCUI 197446 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Carisoprodol
2101IN
-
Carisoprodol
-
Brand names 2
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Soma
204362BN -
Vanadom
220735BN
-
Soma
-
Dose forms 12
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Carisoprodol Oral Tablet
371288SCDF -
Carisoprodol Oral Product
1151411SCDG -
Carisoprodol Pill
1151412SCDG -
Carisoprodol Oral Tablet [Soma]
94126SBDF -
Carisoprodol Oral Tablet [Vanadom]
368177SBDF -
Soma Oral Product
1185413SBDG -
Soma Pill
1185414SBDG -
Vanadom Oral Product
1187375SBDG - +4 more in this family
-
Carisoprodol Oral Tablet
-
Clinical & branded drugs 5
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Carisoprodol 350 MG
315571SCDC -
Carisoprodol 350 MG Oral Tablet [Soma]
213695SBD -
Carisoprodol 350 MG Oral Tablet [Vanadom]
213696SBD -
Carisoprodol 350 MG [Soma]
573558SBDC -
Carisoprodol 350 MG [Vanadom]
573559SBDC
-
Carisoprodol 350 MG
Showing up to 8 concepts per family — 16 of 20 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Carisoprodol 350 MG
SCDC · 315571 -
Carisoprodol Oral Tablet
SCDF · 371288 -
Carisoprodol Oral Product
SCDG · 1151411 -
Carisoprodol Pill
SCDG · 1151412
Brand-Name Concepts
-
Carisoprodol 350 MG Oral Tablet [Soma]
SBD · 213695 -
Carisoprodol 350 MG Oral Tablet [Vanadom]
SBD · 213696 -
Carisoprodol 350 MG [Soma]
SBDC · 573558 -
Carisoprodol 350 MG [Vanadom]
SBDC · 573559 -
Carisoprodol Oral Tablet [Soma]
SBDF · 94126 -
Carisoprodol Oral Tablet [Vanadom]
SBDF · 368177 -
Soma Oral Product
SBDG · 1185413 -
Soma Pill
SBDG · 1185414 -
Vanadom Oral Product
SBDG · 1187375 -
Vanadom Pill
SBDG · 1187376
📦 FDA Products & Package NDCs
51 products · 147 package NDCs
147 package NDCs map to RxCUI 197446 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 71610-0761-60 | 90 TABLET in 1 BOTTLE (71610-761-60) | Carisoprodol | Aphena Pharma Solutions - Tennessee, LLC | 2023-12-05 |
| 71610-0761-70 | 120 TABLET in 1 BOTTLE (71610-761-70) | Carisoprodol | Aphena Pharma Solutions - Tennessee, LLC | 2023-12-05 |
| 71610-0761-75 | 150 TABLET in 1 BOTTLE (71610-761-75) | Carisoprodol | Aphena Pharma Solutions - Tennessee, LLC | 2023-12-05 |
| 72162-1524-00 | 1000 TABLET in 1 BOTTLE (72162-1524-0) | CARISOPRODOL | Bryant Ranch Prepack | 2024-01-23 |
| 72162-1524-01 | 100 TABLET in 1 BOTTLE (72162-1524-1) | CARISOPRODOL | Bryant Ranch Prepack | 2024-01-23 |
| 72162-1524-05 | 500 TABLET in 1 BOTTLE (72162-1524-5) | CARISOPRODOL | Bryant Ranch Prepack | 2024-01-23 |
| 72162-1928-01 | 100 TABLET in 1 BOTTLE (72162-1928-1) | Carisoprodol | Bryant Ranch Prepack | 2020-01-20 |
| 72162-2525-00 | 1000 TABLET in 1 BOTTLE (72162-2525-0) | Carisoprodol Tablets, USP, 350 mg | Bryant Ranch Prepack | 2025-07-22 |
| 72162-2525-01 | 100 TABLET in 1 BOTTLE (72162-2525-1) | Carisoprodol Tablets, USP, 350 mg | Bryant Ranch Prepack | 2025-07-22 |
| 72162-2525-02 | 100 TABLET in 1 BOTTLE (72162-2525-2) | Carisoprodol Tablets, USP, 350 mg | Bryant Ranch Prepack | 2025-07-22 |
| 72189-0310-30 | 30 TABLET in 1 BOTTLE (72189-310-30) | CARISOPRODOL | Directrx | 2022-01-17 |
| 72189-0310-60 | 60 TABLET in 1 BOTTLE (72189-310-60) | CARISOPRODOL | Directrx | 2022-01-17 |
| 72189-0310-72 | 120 TABLET in 1 BOTTLE (72189-310-72) | CARISOPRODOL | Directrx | 2022-01-17 |
| 72189-0310-90 | 90 TABLET in 1 BOTTLE (72189-310-90) | CARISOPRODOL | Directrx | 2022-01-17 |
| 72189-0386-30 | 30 TABLET in 1 BOTTLE (72189-386-30) | Carisoprodol | Direct_Rx | 2022-10-12 |
| 72189-0386-72 | 120 TABLET in 1 BOTTLE (72189-386-72) | Carisoprodol | Direct_Rx | 2022-10-12 |
| 72189-0386-90 | 90 TABLET in 1 BOTTLE (72189-386-90) | Carisoprodol | Direct_Rx | 2022-10-12 |
| 72789-0182-01 | 100 TABLET in 1 BOTTLE, PLASTIC (72789-182-01) | Carisoprodol | PD-Rx Pharmaceuticals, Inc. | 2021-04-26 |
| 72789-0182-90 | 90 TABLET in 1 BOTTLE, PLASTIC (72789-182-90) | Carisoprodol | PD-Rx Pharmaceuticals, Inc. | 2024-05-02 |
| 72789-0182-95 | 1000 TABLET in 1 BOTTLE, PLASTIC (72789-182-95) | Carisoprodol | PD-Rx Pharmaceuticals, Inc. | 2021-04-26 |
| 72789-0182-98 | 120 TABLET in 1 BOTTLE, PLASTIC (72789-182-98) | Carisoprodol | PD-Rx Pharmaceuticals, Inc. | 2024-05-02 |
| 72789-0190-14 | 14 TABLET in 1 BOTTLE, PLASTIC (72789-190-14) | Carisoprodol | PD-Rx Pharmaceuticals, Inc. | 2021-05-26 |
| 72789-0190-30 | 30 TABLET in 1 BOTTLE, PLASTIC (72789-190-30) | Carisoprodol | PD-Rx Pharmaceuticals, Inc. | 2021-05-20 |
| 72789-0190-98 | 120 TABLET in 1 BOTTLE, PLASTIC (72789-190-98) | Carisoprodol | PD-Rx Pharmaceuticals, Inc. | 2022-08-03 |
| 72789-0477-01 | 100 TABLET in 1 BOTTLE, PLASTIC (72789-477-01) | Carisoprodol Tablets, USP, 350 mg | PD-Rx Pharmaceuticals, Inc. | 2025-05-11 |
| 72789-0477-30 | 30 TABLET in 1 BOTTLE, PLASTIC (72789-477-30) | Carisoprodol Tablets, USP, 350 mg | PD-Rx Pharmaceuticals, Inc. | 2025-10-23 |
| 72789-0477-90 | 90 TABLET in 1 BOTTLE, PLASTIC (72789-477-90) | Carisoprodol Tablets, USP, 350 mg | PD-Rx Pharmaceuticals, Inc. | 2025-08-06 |
| 72789-0477-95 | 1000 TABLET in 1 BOTTLE, PLASTIC (72789-477-95) | Carisoprodol Tablets, USP, 350 mg | PD-Rx Pharmaceuticals, Inc. | 2025-05-11 |
| 72789-0477-98 | 120 TABLET in 1 BOTTLE, PLASTIC (72789-477-98) | Carisoprodol Tablets, USP, 350 mg | PD-Rx Pharmaceuticals, Inc. | 2025-08-12 |
| 76420-0646-01 | 100 TABLET in 1 BOTTLE (76420-646-01) | CARISOPRODOL | Asclemed USA, Inc. | 2023-11-29 |
| 76420-0646-30 | 30 TABLET in 1 BOTTLE (76420-646-30) | CARISOPRODOL | Asclemed USA, Inc. | 2023-11-29 |
| 76420-0646-60 | 60 TABLET in 1 BOTTLE (76420-646-60) | CARISOPRODOL | Asclemed USA, Inc. | 2023-11-29 |
| 76420-0646-90 | 90 TABLET in 1 BOTTLE (76420-646-90) | CARISOPRODOL | Asclemed USA, Inc. | 2023-11-29 |
| 76420-0852-01 | 100 TABLET in 1 BOTTLE (76420-852-01) | carisoprodol | Asclemed USA, Inc. | 2024-09-12 |
| 76420-0852-30 | 30 TABLET in 1 BOTTLE (76420-852-30) | carisoprodol | Asclemed USA, Inc. | 2024-09-12 |
| 76420-0852-60 | 60 TABLET in 1 BOTTLE (76420-852-60) | carisoprodol | Asclemed USA, Inc. | 2024-09-12 |
| 76420-0852-90 | 90 TABLET in 1 BOTTLE (76420-852-90) | carisoprodol | Asclemed USA, Inc. | 2024-09-12 |
| 76420-0853-00 | 1000 TABLET in 1 BOTTLE (76420-853-00) | carisoprodol | Asclemed USA, Inc. | 2024-09-12 |
| 76420-0853-01 | 100 TABLET in 1 BOTTLE (76420-853-01) | carisoprodol | Asclemed USA, Inc. | 2024-09-12 |
| 76420-0853-05 | 500 TABLET in 1 BOTTLE (76420-853-05) | carisoprodol | Asclemed USA, Inc. | 2024-09-12 |
| 76420-0853-30 | 30 TABLET in 1 BOTTLE (76420-853-30) | carisoprodol | Asclemed USA, Inc. | 2024-09-12 |
| 76420-0853-60 | 60 TABLET in 1 BOTTLE (76420-853-60) | carisoprodol | Asclemed USA, Inc. | 2024-09-12 |
| 76420-0853-90 | 90 TABLET in 1 BOTTLE (76420-853-90) | carisoprodol | Asclemed USA, Inc. | 2024-09-12 |
| 80425-0291-01 | 30 TABLET in 1 BOTTLE (80425-0291-1) | Carisoprodol | Advanced Rx Pharmacy of Tennessee, LLC | 2023-03-31 |
| 80425-0291-02 | 60 TABLET in 1 BOTTLE (80425-0291-2) | Carisoprodol | Advanced Rx Pharmacy of Tennessee, LLC | 2023-03-31 |
| 80425-0291-03 | 90 TABLET in 1 BOTTLE (80425-0291-3) | Carisoprodol | Advanced Rx Pharmacy of Tennessee, LLC | 2023-03-31 |
| 82868-0062-30 | 30 TABLET in 1 BOTTLE, PLASTIC (82868-062-30) | CARISOPRODOL | Northwind Health Company, LLC | 2024-08-01 |
Observed labelers:
Bryant Ranch Prepack (42) ·
Asclemed USA, Inc. (14) ·
PD-Rx Pharmaceuticals, Inc. (12) ·
Proficient Rx LP (11) ·
Aphena Pharma Solutions - Tennessee, LLC (9) ·
Aurobindo Pharma Limited (8)
· +19 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.